Historical Budget Information | National Institutes of Health (NIH)

Skip to main content Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Breadcrumb Historical Budget Information Historical Budget Information Appropriations Section 1 Amounts in thousands of dollars FY NCI11 NHLBI NIDCR NIDDK1 NINDS2 NIAID12 NIGMS NICHD3 NEI NIEHS4 NIA NIAMS NIDCD NIMH5 1938 400 1939 400 1940 570 1941 570 1942 565 1943 535 1944 530 1945 561 1946 549 1947 1,821 1948 14,500 1949 14,000 1950 18,900 10,725 1,780 9,234 1951 20,086 14,200 1,955 14,200 1952 19,657 10,083 1,618 9,813 1953 17,887 12,000 1,650 10,474 1954 20,237 15,168 1,740 7,000 4,500 5,738 11,741 1955 21,737 16,668 1,990 8,270 7601 6,180 14,030 1956 24,978 18,898 2,176 10,840 9,861 7,775 18,052 1957 48,432 33,396 6,026 15,885 18,650 13,299 30,006 1958 56,402 35,936 6,430 20,385 21,387 17,400 38,457 1959 75,268 45,613 7,420 31,215 29,403 24,071 49,853 1960 91,257 62,237 10,019 46,862 41,487 34,054 67,470 1961 111,000 86,900 15,500 61,200 56,600 44,000 91,923 1962 142,836 132,912 17,340 81,831 70,812 56,091 3,036 107,711 1963 155,742 147,398 21,199 103,388 83,506 66,142 3,523 139,517 1964 144,340 132,404 19,689 113,679 87,675 68,723 (34,000) 170,990 1965 150,011 124,824 20,083 113,050 87,821 69,847 42,696 186,068 1966 163,768 141,462 23,677 123,203 101,153 77,987 127,188 55,024 226,588 1967 175,656 164,770 28,308 135,687 116,296 90,670 145,113 64,922 24,298 1968 183,356 167,954 30,307 143,954 128,633 94,422 160,284 68,621 17,289 1969 185,150 166,928 29,984 143,888 128,935 96,841 163,514 73,127 17,820 1970 181,454 160,634 28,754 131,761 97,315 97,342 148,294 76,095 22,828 17,423 1971 233,160 194,925 35,440 137,986 103,502 102,368 160,194 94,760 30,032 20,151 1972 378,794 232,627 43,388 153,337 116,732 109,117 173,474 116,427 37,132 26,436 1973 492,205 300,000 46,991 167,316 130,672 113,414 183,171 130,429 38,562 30,956 1974 527,486 289,550 43,959 153,561 121,358 111,089 168,329 125,455 41,177 28,397 1975 691,666 324,630 50,033 173,514 142,498 119,452 187,400 142,435 44,133 35,171 1976 761,727 370,013 51,291 179,516 144,446 126,852 187,312 136,404 50,212 37,660 19,288 1976 TQ 152,901 58,763 7,854 43,719 34,272 27,638 34,078 24,201 4,038 9,519 8,743 1977 815,000 396,661 55,573 219,600 155,500 141,000 205,000 145,543 64,000 51,141 30,000 1978 872,388 447,909 61,728 260,253 178,438 162,341 230,796 166,390 85,400 64,241 37,305 1979 937,129 510,526 65,213 302,767 212,365 191,328 277,628 197,630 105,192 78,080 56,911 1980 999,869 527,488 68,303 341,206 241,966 215,364 312,468 208,953 112,989 83,893 69,988 1981 989,355 549,693 71,114 369,462 252,533 232,077 333,764 220,628 117,983 93,491 75,608 1982 986,617 559,637 71,983 368,191 265,901 235,895 339,862 226,309 127,374 106,270 81,903 1983 987,642 624,259 79,292 413,492 297,064 279,129 369,813 254,324 141,901 164,867 93,996 1984 1,081,581 704,939 88,674 464,026 335,883 319,596 415,937 276,046 155,131 180,597 115,292 1985 1,183,806 805,269 100,688 543,576 396,885 370,965 482,260 313,295 181,678 194,819 144,521 1986 1,203,369 822,292 98,841 544,858 414,727 366,964 492,630 307,958 186,705 188,986 149,762 1987 1,402,837 930,001 117,945 511,124 490,233 545,523 570,916 366,780 216,637 209,294 177,681 138,713 1988 1,469,327 965,536 126,297 534,733 534,692 638,800 632,676 396,811 224,947 215,666 194,746 147,679 1989 1,570,349 1,045,509 130,709 559,494 472,292 740,257 682,213 425,375 231,170 223,403 222,639 159,891 94,166 1990 1,634,332 1,072,354 135,749 581,477 490,409 832,977 681,782 442,914 236,533 229,234 239,455 168,930 117,583 1991 1,714,784 1,126,942 148,918 615,272 541,743 906,251 760,010 478,956 253,241 241,028 323,752 193,247 134,935 1992 1,962,587 1,188,593 158,417 658,925 577,938 959,082 816,844 518,251 268,978 248,575 383,382 203,047 148,789 1993 1,981,351 1,214,793 161,301 681,342 600,078 979,471 832,581 527,788 276,188 251,187 399,924 212,456 154,814 583,651 1994 2,082,267 1,277,880 169,520 716,054 630,650 1,065,593 875,511 555,195 290,260 264,249 420,303 223,280 162,823 613,444 1995 1,913,819 1,257,374 162,430 726,949 627,045 535,199 876778 512,165 291,095 266,566 431,991 228,176 166,660 542,200 1996 2,248,000 1,354,946 182,923 770,582 680,902 1,168,483 946,896 594,547 313,933 288,378 453,541 241,655 176,383 660,549 1997 2,381,149 1,432,529 195,825 815,607 726,407 1,256,659 998,387 631,365 332,597 308,487 485,806 257,003 188,345 701,107 1998 2,547,314 1,531,061 209,415 900,860 780,713 1,351,655 1,065,947 674,766 355,691 330,108 519,279 274,760 200,695 750,241 1999 2,925,247 1,792,509 234,183 1,020,559 902,680 1,569,063 1,197,026 750,485 395,595 375,494 596,126 307,960 229,735 860,638 2000 3,314,554 2,029,424 268,811 1,168,476 1,029,376 1,798,038 1,354,420 858,291 450,300 442,449 686,479 349,968 263,771 973,146 2001 3,754,456 2,298,512 306,211 1,399,684 1,175,854 2,042,124 1,535,378 975,766 510,352 564,810 785,590 396,460 300,418 1,106,305 2002 4,181,233 2,572,667 342,664 1,562,144 1,326,666 2,367,313 1,724,799 1,111,674 580,713 645,422 892,267 448,248 341,675 1,246,640 2003 4,592,348 2,793,733 371,636 1,722,730 1,456,476 3,706,722 1,847,000 1,205,927 633,148 697,767 993,598 486,143 370,382 1,341,014 2004 4,739,255 2,878,691 383,282 1,821,803 1,501,207 4,304,562 1,904,838 1,242,361 653,052 710,701 1,024,754 501,066 382,053 1,381,774 2005 4,825,258 2,941,201 391,829 1,863,584 1,539,448 4,402,841 1,944,067 1,270,321 669,070 724,347 1,051,990 511,157 394,260 1,411,933 2006 4,793,356 2,921,757 389,336 1,854,925 1,534,757 4,414,801 1,935,618 1,264,769 666,756 720,240 1,046,631 507,932 393,458 1,403,515 2007 4,797,639 2,922,929 389,703 1,855,868 1,535,545 4,417,208 1,935,808 1,254,707 667,116 721,119 1,047,260 508,240 393,668 1,404,494 2008 4,830,647 2,938,470 391,778 1,864,945 1,552,113 4,583,344 1,946,104 1,261,381 670,664 723,215 1,052,830 511,291 396,234 1,412,951 2009 4,968,973 3,015,689 402,652 1,911,338 1,593,344 4,702,572 1,997,801 1,294,894 688,480 740,894 1,080,796 524,872 407,259 1,450,491 2010 5,103,388 3,096,916 413,236 1,958,100 1,636,371 4,818,275 2,051,798 1,329,528 707,036 768,993 1,110,229 539,082 418,833 1,489,372 2011 5,058,577 3,069,723 409,608 1,942,224 1,622,003 4,775,968 2,033,782 1,317,854 700,828 762,778 1,100,481 534,349 415,155 1,476,294 2012 5,072,183 3,079,021 410,710 1,947,044 1,626,365 4,490,711 2,430,036 1,321,398 702,712 764,498 1,103,441 535,786 416,273 1,480,265 201313 4,807,450 2,918,317 389,274 1,845,601 1,541,480 4,256,327 2,303,204 1,252,430 666,036 724,597 1,045,849 507,822 394,546 1,403,005 2014 4,923,238 2,988,605 398,650 1,883,474 1,587,982 4,358,841 2,364,147 1,282,595 682,077 742,788 1,171,038 520,053 404,049 1,446,172 2015 15 4,950,396 2,997,870 399,886 1,899,681 1,605,205 4,358,841 2,371,476 1,286,571 684,191 744,851 1,199,468 521,665 405,302 1,463,036 2016 16 5,214,701 3,115,538 415,582 1,968,357 1,696,139 4,629,928 2,512,073 1,339,802 715,903 771,051 1,600,191 542,141 423,031 1,548,390 2017 17, 18 5,689,329 3,206,589 425,751 2,010,245 1,783,654 4,906,638 2,650,838 1,380,295 732,618 791,610 2,048,610 557,851 436,875 1,601,931 2018 17, 19 5,964,800 3,383,201 447,735 2,120,797 2,188,149 5,260,210 2,785,400 1,452,006 772,317 828,492 2,574,091 586,661 459,974 1,754,775 2019 17, 20 6,143,892 3,488,335 461,781 2,179,823 2,274,413 5,523,324 2,872,780 1,506,458 796,536 852,056 3,083,410 605,065 474,404 1,870,296 2020 17, 21, 22 6,440,442 3,624,258 477,429 2,264,314 2,444,687 5,885,470 2,937,218 1,556,879 824,090 883,598 3,543,673 624,889 490,692 2,038,374 2021 17, 22, 23 6,559,852 3,664,811 484,867 2,281,975 2,513,393 6,069,619 2,991,417 1,590,337 835,714 896,175 3,899,227 634,292 498,076 2,103,708 2022 17, 24 6,912,522 3,808,494 501,231 2,345,376 2,611,370 6,322,728 3,092,373 1,683,009 863,918 924,709 4,219,936 655,699 514,885 2,216,976 2023 17, 25 7,320,159 3,982,345 520,163 2,442,171 2,813,925 6,562,279 3,239,679 1,749,078 896,549 997,014 4,407,623 685,465 534,333 2,337,843 2024 17, 26 7,224,159 3,982,345 520,163 2,506,474 2,689,925 6,562,279 3,244,679 1,759,078 896,549 993,693 4,507,623 685,465 534,333 2,273,843 1 Beginning in FY 1998, annual levels includes amounts received by the NIDDK consistent with the Special Statutory Funding Program for Type 1 Diabetes Research (special type 1 diabetes), unrelated to their annual appropriations, as initially authorized under Public Law (P.L.) 105-33 (now Section 330B of the Public Health Service Act) and subsequently re-authorized in 2001, 2007, 2008, 2010 and 2012. Between FY 1998-2000, NIDDK received $30.0 million in ‘mandatory’ budget authority each year followed by an increase to an annual level of $100.0 million for FY 2001 through FY 2003. Beginning in FY 2004 continuing through FY 2012, NIDDK has received budget authority of $150.0 million annually for special type 1 diabetes research purposes. For additional information, refer to the program and budget summary maintained by NIDDK at https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program. 2 Starting in 1970, excludes funds for blindness, established as a separate appropriation, the “National Eye Institute.” 3 Congress authorized the transfer of $34,000 from other NIH appropriations to establish the “National Institute of Child Health and Human Development.” Starting in 1976, excludes funds for aging, established as a separate appropriation, the “National Institute on Aging.” 4 In FY 2001, NIH first received a separate appropriation to fund its participation in Superfund Research Program (SRP) activity performed at NIEHS. A significant change occurred in 2000 when Congress chose to provide funding support directly to NIEHS. Previously, the SRP received its funds as pass through dollars from the U.S. Environmental Protection Agency (EPA). From 2000-2005, jurisdiction for SRP funding was assigned to the House Veterans Affairs, Housing and Urban Development and Independent Agencies Appropriation Subcommittee. In 2005, both the House and Senate restructured their Appropriation subcommittees. As a result of this reorganization, budget review jurisdiction for the SRP was assigned to the Appropriation Subcommittee on Interior, Environment, and Related Agencies. A detailed breakdown of budget authority received annually for SRP is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 5 NIMH separated from NIH in 1967 and was raised to bureau status in PHS, became a component of PHS's Health Services and Mental Health Administration (HSMHA), later became a component of ADAMHA (successor organization of HSMHA), and rejoined the NIH in 1993. 6 Funding for General Research and Services (GR&S) is shown for FY 1938 to FY 1962, at which time the Division of Research Facilities and Resources (DRFR) was established. In 1969, the Bureau of Health Manpower was renamed the Bureau of Health Professions Education and Manpower Training (BEMT). Within the BEMT, the Division of Research Resources (DRR) was established. Functions of DRFR were transferred to this new Division. In 1970, DRR transferred out of this Bureau. Renamed the National Center for Research Resources in 1990. 7 Starting in 1966, excludes funds for the newly established “National Institute of General Medical Sciences.” Starting in 1970, excludes the “Office of International Operations,” transferred to the “National Institute of Allergy and Infectious Diseases” and the “John E. Fogarty International Center for Advanced Study in the Health Sciences.” 8 Prior to 1970, funds were included under the National Institutes of Health Management Fund. Separate NIH appropriation enacted in 1970. 9 Prior to 1970, Buildings and Facilities funds were included under PHS. Separate NIH appropriation enacted in 1970. 10 “Office of AIDS Research.” 11 Includes amounts specified for facilities repairs and improvements at the National Cancer Institute—Frederick Federally Funded Research and Development Center in Frederick, MD. B&F, often referred to as NCI-Construction. A detailed breakdown of budget authority received for NCI-Construction is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 12 Between FY 2002 and FY 2011, the total includes amounts specified for the “Global Fund for HIV/AIDS, malaria, and tuberculosis” (Global Fund) to be transferred to another federal agency. As of FY 2012, NIAID no longer receives appropriations for Global Fund subject to transfer. A detailed breakdown of budget authority received for Global Fund transfer is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 13 Amounts reflect post-sequestration levels consistent with the OMB March implementation report defining reductions mandated under the American Taxpayer Relief Act of 2012 (P.L. 112-240), Budget Control Act of 2011 (P.L. 112-25) plus Consolidated and Further Continuing Appropriations Act of 2013 (P.L. 113-6). IC levels and NIH total exclude allocations derived from the Super Storm Sandy supplemental appropriations act, P.L. 113-2, “Disaster Relief Appropriations Act”, 2013. 14 Funds reflect enacted levels as provided under the Consolidated and Continuing Appropriations Act of 2014 (PL 113-76). The name of the National Center for Complementary and Alternative Medicine (NCCAM) has been changed to National Center for Complementary and Integrative Health (NCCIH) in FY 2015 per the Consolidated and Further Continuing Appropriations Act of 2014 (PL 113-235). Future revisions of this table will indicate NCCIH replacing the NCCAM abbreviation. 15 Funds reflect enacted levels as provided under the Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235). 16 Funds reflect enacted levels as provided under the Consolidated Appropriations Act of 2016 (P.L. 114-113). 17 The 21st Century Cures Act, 2016 (P.L. 114-255) authorized $4.8 billion to NIH over a 10 year period, with initial allocations in FY 2017. For FY 2020, a total of $492 million was appropriated: $195 million for NCI, $70 million for each of NINDS and NIMH, and $157 million for OD. For FY 2021, a total of $404 million was appropriated: $195 million for NCI, $50 million each for NINDS and NIMH, and $109 million for OD. For FY 2022, a total of $496 million was appropriated: $194 million for NCI, $76 million each for NINDS and NIMH, and $150 million for OD. For FY 2023, a total of $1.085 billion was appropriated: $216 million for NCI, $225 million each for NINDS and NIMH, and $419 million for OD. For FY 2024, a total of $407 million was appropriated: $86 million each for NINDS and NIMH, and $235 million for OD. 18 Discretionary resources of approximately $34.1 billion were received under the Consolidated Appropriations Act, 2017 (Public Law 115-31) as well as $824.443 million derived from PHS Evaluation financing identified in the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation was reduced from the FY 2016 level of $150 million to $139.65 million due to sequestration. In addition to other funds appropriated for the OD from P.L. 115-31, $12.6 million is provided to the OD Common Fund from the 10-year Pediatric Research Initiative Fund described in section 9008 of title 26, United States Code. 19 Discretionary resources of nearly $36.24 billion received under the Consolidated Appropriations Act, 2018 (P.L. 115-141) as well as $922.871 million derived from PHS Evaluation financing associated with the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation of $150 million was authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123). 20 Discretionary resources of nearly $37.94 billion received under the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245), excluding Superfund Research. An additional $77.3 million in discretionary authority is provided in NIEHS allocation for Superfund Research which is currently under a Continuing Resolution through December 7, 2018 (P.L. 115-245) later extended by another C.R. into February 2019 (P.L. 116-5). NIGMS allocation includes $1,147 million derived from PHS Evaluation financing. Mandatory funding for the Special type 1 diabetes account is included in the NIDDK allocation of $150 million as authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123). 21 NIH Program Level of $41.64 billion is comprised primarily of $40.31 billion discretionary appropriations received under Further Consolidated Appropriations Act, 2020 (P.L. 116-94). The discretionary sum include $81 million provided in NIEHS allocation for Superfund Research. Additional resources involve PHS Evaluation for NIGMS and Mandatory account funding for NIDDK. NIGMS level includes $1.231 billion derived from PHS Evaluation financing. Special type 1 diabetes mandatory dollars for NIDDK totaled $150 million. 22 Amounts exclude supplemental appropriations enacted in FY 2020 for COVID-19 research from P.L. 116-123, P.L. 116-136, P.L. 116-139, and P.L. 116-260. IC distribution of the additional budgetary resources for COVID-19 supplemental appropriations is furnished in the OB website's Appropriation History for FY 2020-2022 Supplementary Data Table. 23 Discretionary resources of slightly over $41.5 billion received under the Consolidated Appropriations Act, 2021 (P.L. 116-260). NIGMS allocation includes $1.272 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding for the Special type 1 diabetes account of $150 million. 24 Discretionary resources of slightly over $43.7 billion received under the Consolidated Appropriations Act, 2022 (P.L. 117-103). NIGMS allocation includes $1.309 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding of $141.450 million for the Special type 1 diabetes account. Note that P.L. 117-103 authorized the establishment of Advanced Research Projects Agency for Health (ARPA-H) within the Department Health and Human Services with authority to transfer to NIH. 25 Discretionary resources of slightly over $46.1 billion received under the Consolidated Appropriations Act, 2023 (P.L. 117-328). NIGMS allocation includes $1.412 billion derived from PHS Evaluation financing and NIDDK includes $141.5 million mandatory funding for the Special type 1 diabetes account. P.L. 117-328 appropriated $1.5 billion for ARPA-H within the Department of Health and Human Services with authority to transfer to NIH. 26 Discretionary resources of slightly over $47.2 billion received under the Consolidated Appropriations Act, 2024 (P.L. 118-42) and the Further Consolidated Appropriations Act, 2024 (P.L. 118-47). NIGMS allocation includes $1.412 billion derived from PHS Evaluation financing and NIDDK includes $195.8 million mandatory funding for the Special type 1 diabetes account. Section 2 Amounts in thousands of dollars FY NIDA NIAAA NINR NHGRI NIBIB NIMHD NCRR6,7 NCCIH14 NCATS FIC NLM OD8 ARPA-H B&F9 OAR10 Total 1938 64 464 1939 64 464 1940 137 707 1941 141 711 1942 135 700 1943 743 1,278 1944 2,205 2,735 1945 2,274 2,835 1946 2,866 3,415 1947 6,254 8,075 1948 10,126 24,626 1949 14,540 28,540 1950 12,075 52,714 1951 14,314 64,755 1952 15,757 56,928 1953 16,599 58,610 1954 4,675 70,799 1955 4,675 81,151 1956 5,929 98,509 1957 12,122 177,816 1958 14,026 210,423 1959 28,974 291,817 1960 45,994 399,380 1961 83,900 551,023 1962 127,637 740,206 1963 159,826 880,241 1964 163,869 867,369 1965 164,759 959,159 1966 60,469 1,100,519 1967 68,534 1,014,254 1968 81,141 500 1,076,461 1969 84,810 600 18,160 1,109,757 1970 67,925 2,775 19,251 7,541 1,615 1,061,007 1971 66,320 3,666 21,440 8,903 1,212,847 1972 74,981 4,307 24,127 11,712 3,565 1,506,156 1973 75,073 4,666 28,568 12,042 8,500 1,762,565 1974 129,426 4,767 25,871 12,000 8,000 1,790,425 1975 127,200 5,589 28,850 17,326 3,000 2,092,897 1976 130,265 5,705 29,065 18,370 54,000 2,302,126 1976 TQ 20,282 1,135 6,572 4,642 750 439,107 1977 137,500 7,992 35,234 16,394 67,400 2,543,538 1978 145,095 8,483 37,619 18,900 65,650 2,842,936 1979 154,164 8,989 41,431 19,673 30,950 3,189,976 1980 169,196 8,987 43,979 21,036 3,250 3,428,935 1981 175,627 9,124 44,666 22,531 11,750 3,569,406 1982 184,177 9,205 45,035 23,618 9,898 3,641,875 1983 213,917 10,147 51,943 24,683 17,500 4,023,969 1984 243,177 11,336 49,613 26,720 25,040 4,493,588 1985 304,025 11,728 55,910 38,304 21,730 5,149,459 1986 292,523 11,054 55,322 111,961 14,259 5,262,211 1987 20,000 322,860 11,420 61,838 57,208 31,900 6,182,910 1988 23,380 368,153 15,651 67,910 61,819 47,870 6,666,693 1989 29,133 358,076 15,790 73,731 72,076 38,492 7,144,765 1990 33,513 59,538 353,734 15,516 81,861 107,419 61,042 7,576,352 1991 39,722 87,418 335,255 17,519 91,408 95,651 168,687 8,274,739 1992 44,929 104,762 314,213 19,593 99,088 141,854 103,840 8,921,687 1993 403,806 176,619 48,119 106,239 312,468 19,733 113,031 190,325 108,731 10,335,996 1994 425,201 185,617 51,018 128,701 331,915 21,677 119,981 233,605 111,039 10,955,783 1995 290,029 181,150 48,164 151,518 284,693 14,646 125,303 217,882 114,120 1,333,570 11,299,522 1996 458,112 198,401 55,814 169,768 390,298 25,292 140,936 261,072 146,151 11,927,562 1997 489,160 211,870 59,721 189,529 415,095 26,557 150,828 286,810 200,000 12,740,843 1998 527,175 227,175 63,597 217,704 453,883 28,289 161,185 296,373 206,957 13,674,843 1999 602,874 259,575 69,788 264,707 554,446 35,402 181,189 306,356 197,519 15,629,156 2000 685,781 292,369 89,522 335,527 676,557 68,390 43,494 214,068 282,000 165,376 17,840,587 2001 780,833 340,453 104,328 382,112 130,096 817,253 89,138 50,482 246,351 211,800 153,790 20,458,556 2002 886,718 383,615 120,366 428,758 111,861 157,563 1,011,262 104,451 56,859 276,091 235,113 204,600 23,321,382 2003 961,721 416,051 130,584 464,995 278,279 185,714 1,138,821 113,407 63,465 300,135 266,232 628,687 27,166,715 2004 990,953 428,669 134,724 479,073 287,129 191,471 1,179,058 116,978 65,382 317,315 327,504 88,972 28,036,627 2005 1,006,419 438,277 138,072 488,608 298,209 196,159 1,115,090 122,105 66,632 315,146 358,046 110,288 28,594,357 2006 1,000,029 435,930 137,342 486,049 296,810 195,405 1,099,101 121,465 66,378 314,910 478,066 81,081 28,560,417 2007 1,000,621 436,259 137,404 486,491 296,887 199,444 1,133,240 121,576 66,446 320,850 1,046,901 81,081 29,178,504 2008 1,006,022 438,579 138,207 489,368 300,233 200,630 1,155,560 122,224 66,912 322,667 1,111,735 118,966 29,607,070 2009 1,032,759 450,230 141,879 502,367 308,208 205,959 1,226,263 125,471 68,691 330,771 1,246,864 125,581 30,545,098 2010 1,059,848 462,346 145,660 516,028 316,582 211,572 1,268,896 128,844 70,051 339,716 1,177,300 100,000 31,238,000 2011 1,050,542 458,286 144,381 511,497 313,802 209,714 1,257,754 127,713 69,436 336,733 1,166,963 49,900 30,916,345 2012 1,053,367 459,519 144,769 512,873 338,357 276,440 128,057 575,366 69,622 337,639 1,459,117 125,344 30,860,913 2013 13 998,389 435,535 137,213 486,104 320,697 262,011 121,373 545,336 65,988 320,016 1,448,420 118,802 29,315,822 2014 1,025,435 446,025 140,517 497,813 329,172 268,322 124,296 633,267 67,577 327,723 1,400,134 128,663 30,142,653 2015 15 1,028,614 447,408 140,953 499,356 330,192 269,154 124,681 635,230 67,786 336,939 1,413,734 128,863 30,311,349 2016 16, 17 1,077,488 467,700 146,485 518,956 346,795 279,718 130,789 685,417 70,447 394,664 1,571,200 128,863 32,311,349 2017 17, 18 1,090,853 483,363 150,273 528,566 357,080 289,069 134,689 705,903 72,213 407,510 1,729,783 128,863 34,300,999 2018 17, 19 1,383,603 509,573 158,033 556,881 377,871 303,200 142,184 742,354 75,733 428,553 1,925,893 128,863 37,311,349 2019 17, 20 1,419,844 525,591 162,992 575,579 389,464 314,679 146,473 806,373 78,109 441,997 2,117,675 200,000 39,311,349 2020 17, 21,22 1,462,016 545,373 169,113 606,349 403,638 335,812 151,740 832,888 80,760 456,911 2,409,387 200,000 41,690,000 2021 17, 22, 23 1,479,660 554,923 174,957 615,780 410,728 390,865 154,162 855,421 84,044 463,787 2,532,710 200,000 42,940,500 2022 17, 24 1,595,474 573,651 180,862 639,062 424,590 459,056 159,365 882,265 86,880 479,439 2,779,120 250,000 45,182,990 2023 17, 25 1,662,695 595,318 197,693 663,200 440,627 524,395 170,384 923,323 95,162 497,548 3,074,514 350,000 47,683,485 2024 17, 26 1,662,695 595,318 197,693 663,200 440,627 534,395 170,384 928,323 95,162 497,548 2,840,514 1,500,000 350,000 48,856,467 1 Beginning in FY 1998, annual levels includes amounts received by the NIDDK consistent with the Special Statutory Funding Program for Type 1 Diabetes Research (special type 1 diabetes), unrelated to their annual appropriations, as initially authorized under Public Law (P.L.) 105-33 (now Section 330B of the Public Health Service Act) and subsequently re-authorized in 2001, 2007, 2008, 2010 and 2012. Between FY 1998-2000, NIDDK received $30.0 million in ‘mandatory’ budget authority each year followed by an increase to an annual level of $100.0 million for FY 2001 through FY 2003. Beginning in FY 2004 continuing through FY 2012, NIDDK has received budget authority of $150.0 million annually for special type 1 diabetes research purposes. For additional information, refer to the program and budget summary maintained by NIDDK at http://www.t1diabetes.nih.gov/about.shtml. 2 Starting in 1970, excludes funds for blindness, established as a separate appropriation, the “National Eye Institute.” 3 Congress authorized the transfer of $34,000 from other NIH appropriations to establish the “National Institute of Child Health and Human Development.” Starting in 1976, excludes funds for aging, established as a separate appropriation, the “National Institute on Aging.” 4 In FY 2001, NIH first received a separate appropriation to fund its participation in Superfund Research Program (SRP) activity performed at NIEHS. A significant change occurred in 2000 when Congress chose to provide funding support directly to NIEHS. Previously, the SRP received its funds as pass through dollars from the U.S. Environmental Protection Agency (EPA). From 2000-2005, jurisdiction for SRP funding was assigned to the House Veterans Affairs, Housing and Urban Development and Independent Agencies Appropriation Subcommittee. In 2005, both the House and Senate restructured their Appropriation subcommittees. As a result of this reorganization, budget review jurisdiction for the SRP was assigned to the Appropriation Subcommittee on Interior, Environment, and Related Agencies. A detailed breakdown of budget authority received annually for SRP is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 5 NIMH separated from NIH in 1967 and was raised to bureau status in PHS, became a component of PHS's Health Services and Mental Health Administration (HSMHA), later became a component of ADAMHA (successor organization of HSMHA), and rejoined the NIH in 1993. 6 Funding for General Research and Services (GR&S) is shown for FY 1938 to FY 1962, at which time the Division of Research Facilities and Resources (DRFR) was established. In 1969, the Bureau of Health Manpower was renamed the Bureau of Health Professions Education and Manpower Training (BEMT). Within the BEMT, the Division of Research Resources (DRR) was established. Functions of DRFR were transferred to this new Division. In 1970, DRR transferred out of this Bureau. Renamed the National Center for Research Resources in 1990. 7 Starting in 1966, excludes funds for the newly established “National Institute of General Medical Sciences.” Starting in 1970, excludes the “Office of International Operations,” transferred to the “National Institute of Allergy and Infectious Diseases” and the “John E. Fogarty International Center for Advanced Study in the Health Sciences.” 8 Prior to 1970, funds were included under the National Institutes of Health Management Fund. Separate NIH appropriation enacted in 1970. 9 Prior to 1970, Buildings and Facilities funds were included under PHS. Separate NIH appropriation enacted in 1970. 10 “Office of AIDS Research.” 11 Includes amounts specified for facilities repairs and improvements at the National Cancer Institute—Frederick Federally Funded Research and Development Center in Frederick, MD. B&F, often referred to as NCI-Construction. A detailed breakdown of budget authority received for NCI-Construction is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 12 Between FY 2002 and FY 2011, the total includes amounts specified for the “Global Fund for HIV/AIDS, malaria, and tuberculosis” (Global Fund) to be transferred to another federal agency. As of FY 2012, NIAID no longer receives appropriations for Global Fund subject to transfer. A detailed breakdown of budget authority received for Global Fund transfer is found at http://officeofbudget.od.nih.gov/approp_hist.html under the latest appropriations history table, e.g., [2000-2012]. 13 Amounts reflect post-sequestration levels consistent with the OMB March implementation report defining reductions mandated under the American Taxpayer Relief Act of 2012 (P.L. 112-240), Budget Control Act of 2011 (P.L. 112-25) plus Consolidated and Further Continuing Appropriations Act of 2013 (P.L. 113-6). IC levels and NIH total exclude allocations derived from the Super Storm Sandy supplemental appropriations act, P.L. 113-2, “Disaster Relief Appropriations Act”, 2013. 14 Funds reflect enacted levels as provided under the Consolidated and Continuing Appropriations Act of 2014 (PL 113-76). The name of the National Center for Complementary and Alternative Medicine (NCCAM) has been changed to National Center for Complementary and Integrative Health (NCCIH) in FY 2015 per the Consolidated and Further Continuing Appropriations Act of 2014 (PL 113-235). Future revisions of this table will indicate NCCIH replacing the NCCAM abbreviation. 15 Funds reflect enacted levels as provided under the Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235). 16 Funds reflect enacted levels as provided under the Consolidated Appropriations Act of 2016 (P.L. 114-113). 17 The 21st Century Cures Act, 2016 (P.L. 114-255) authorized $4.8 billion to NIH over a 10 year period, with initial allocations in FY 2017. For FY 2020, a total of $492 million was appropriated: $195 million for NCI, $70 million for each of NINDS and NIMH, and $157 million for OD. For FY 2021, a total of $404 million was appropriated: $195 million for NCI, $50 million each for NINDS and NIMH, and $109 million for OD. For FY 2022, a total of $496 million was appropriated: $194 million for NCI, $76 million each for NINDS and NIMH, and $150 million for OD. For FY 2023, a total of $1.085 billion was appropriated: $216 million for NCI, $225 million each for NINDS and NIMH, and $419 million for OD. For FY 2024, a total of $407 million was appropriated: $86 million each for NINDS and NIMH, and $235 million for OD. 18 Discretionary resources of approximately $34.1 billion were received under the Consolidated Appropriations Act, 2017 (Public Law 115-31) as well as $824.443 million derived from PHS Evaluation financing identified in the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation was reduced from the FY 2016 level of $150 million to $139.65 million due to sequestration. In addition to other funds appropriated for the OD from P.L. 115-31, $12.6 million is provided to the OD Common Fund from the 10-year Pediatric Research Initiative Fund described in section 9008 of title 26, United States Code. 19 Discretionary resources of nearly $36.24 billion received under the Consolidated Appropriations Act, 2018 (P.L. 115-141) as well as $922.871 million derived from PHS Evaluation financing associated with the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation of $150 million was authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123). 20 Discretionary resources of nearly $37.94 billion received under the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245), excluding Superfund Research. An additional $77.3 million in discretionary authority is provided in NIEHS allocation for Superfund Research which is currently under a Continuing Resolution through December 7, 2018 (P.L. 115-245) later extended by another C.R. into February 2019 (P.L. 116-5). NIGMS allocation includes $1,147 million derived from PHS Evaluation financing. Mandatory funding for the Special type 1 diabetes account is included in the NIDDK allocation of $150 million as authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123). 21 NIH Program Level of $41.64 billion is comprised primarily of $40.31 billion discretionary appropriations received under Further Consolidated Appropriations Act, 2020 (P.L. 116-94). The discretionary sum include $81 million provided in NIEHS allocation for Superfund Research. Additional resources involve PHS Evaluation for NIGMS and Mandatory account funding for NIDDK. NIGMS level includes $1.231 billion derived from PHS Evaluation financing. Special type 1 diabetes mandatory dollars for NIDDK totaled $150 million. 22 Amounts exclude supplemental appropriations enacted in FY 2020 for COVID-19 research from P.L. 116-123, P.L. 116-136, P.L. 116-139, and P.L. 116-260. IC distribution of the additional budgetary resources for COVID-19 supplemental appropriations is furnished in the OB website's Appropriation History for FY 2020-2022 Supplementary Data Table. 23 Discretionary resources of slightly over $41.5 billion received under the Consolidated Appropriations Act, 2021 (P.L. 116-260). NIGMS allocation includes $1.272 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding for the Special type 1 diabetes account of $150 million. 24 Discretionary resources of slightly over $43.7 billion received under the Consolidated Appropriations Act, 2022 (P.L. 117-103). NIGMS allocation includes $1.309 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding of $141.450 million for the Special type 1 diabetes account. Note that P.L. 117-103 authorized the establishment of Advanced Research Projects Agency for Health (ARPA-H) within the Department Health and Human Services with authority to transfer to NIH. 25 Discretionary resources of slightly over $46.1 billion received under the Consolidated Appropriations Act, 2023 (P.L. 117-328). NIGMS allocation includes $1.412 billion derived from PHS Evaluation financing and NIDDK includes $141.5 million mandatory funding for the Special type 1 diabetes account. P.L. 117-328 appropriated $1.5 billion for ARPA-H within the Department of Health and Human Services with authority to transfer to NIH. 26 Discretionary resources of slightly over $47.2 billion received under the Consolidated Appropriations Act, 2024 (P.L. 118-42) and the Further Consolidated Appropriations Act, 2024 (P.L. 118-47). NIGMS allocation includes $1.412 billion derived from PHS Evaluation financing and NIDDK includes $195.8 million mandatory funding for the Special type 1 diabetes account. This page last reviewed on July 31, 2025 www.nih.gov An official website of the Department of Health and Human Services Looking for U.S. government information and services? Visit USA.gov